SPf66, a candidate synthetic malaria vaccine: Immunogenicity versus protection
- 30 November 1992
- journal article
- editorial
- Published by Elsevier in Parasitology Today
- Vol. 8 (11) , 354-355
- https://doi.org/10.1016/0169-4758(92)90162-u
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccineVaccine, 1992
- Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66Parasite Immunology, 1992
- A specific T‐cell receptor genotype preference in the immune response to a synthetic Plasmodium falciparum malaria vaccineParasite Immunology, 1992
- Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparumParasite Immunology, 1991
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- Towards vaccine optimisationImmunology Letters, 1990
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987
- Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum MalariaScience, 1985